ArticlePhilosophy, ethics, and humanities in medicine : PEHM2026
Legislative recognition and implementation challenges of living wills in China.
Article in Philosophy, ethics, and humanities in medicine : PEHM, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
The 2022 revision of China’s Shenzhen Special Economic Zone Medical Regulations marks the nation’s inaugural legislative recognition of “living wills” as legally binding instruments. However, the implementation of living wills in clinical practice encounters significant ethical challenges, influenced by traditional cultural norms, prevailing medical ethics standards, policy frameworks, healthcare resource allocation, and systemic constraints. To advance this end-of-life care paradigm, we propose a threefold strategy: (1) enhancing public education on death literacy and autonomy, (2) improving the legal procedures for establishing and implementing living wills, and (3) establishing a comprehensive national hospice care safeguard system. These measures are critical to ensuring the protection of terminally ill patients’ fundamental rights and dignity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.